Vericel Corporation is a company in the U.S. stock market and it is a holding in 31 U.S.-traded ETFs. VCEL has around 4.8M shares in the U.S. ETF market. The largest ETF holder of VCEL is the SPDR S&P Biotech ETF (XBI), with approximately 1.97M shares. Investors may also find of interest that the ETF with the largest allocation to VCEL stock is Invesco Dynamic Biotechnology & Genome ETF (PBE), with a portfolio weight of 2.63%. On average, U.S. ETFs allocate 0.17% of VCEL to their portfolios.
Additionally, VCEL is a favorite stock for Vanilla and Fundamental ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with VCEL as a holding is the Principal Healthcare Innovators Index ETF (BTEC), with a return of 33.17%.